Medical Device & Technology

Moximed initiates a trial for its MISHA Knee System, an alternative treatment for knee osteoarthritis, promising pain relief and improved mobility.

A new study outlines how AI might support eVisits. Patients are on board, as long as doctors remain in the driver’s seat.

Company expects to submit to FDA in 2026

GlobalData report says hospitals may be accelerating purchases of certain medical devices

Mark Daly of Digital Diagnostics joins the show to discuss AI diagnostic tools.

Tenovi's new blood pressure monitor enhances stroke prevention by enabling early detection of hypertension and irregular heartbeats through remote patient monitoring.

Aptar Digital Health and AstraZeneca collaborate to revolutionize chronic kidney disease detection using AI algorithms in eye exams, enhancing early diagnosis.

ReGelTec's HYDRAFIL System offers a minimally invasive treatment for chronic low back pain, promising significant pain relief and improved function.

Atia Vision's OmniVu lens system promises a breakthrough in cataract surgery with enhanced vision restoration.

U.S. tariffs are disrupting European medtech growth, forcing firms to adapt supply chains and prioritize cost optimization amid rising challenges and uncertainties.

Fujirebio Diagnostics’ test, which received 510k clearance Friday, will “assist physicians and patients to obtain an AD diagnosis in early stages of the disease.”

The VivAer procedure offers lasting relief for nasal obstruction, transforming NAO treatment with its minimally invasive approach and impressive results.

Medtech CEO warns senate that tariffs could undermine health care and innovation

Synchron integrates brain-computer interface technology with Apple devices, enabling thought-controlled access for individuals with motor impairments.

Veradigm leverages AI to enhance real-world evidence for GLP-1 drugs, revealing insights on patient adherence, side effects, and treatment outcomes.

PCPs welcome AI as a time-saver, but new research shows that many failed to catch serious mistakes in AI-generated patient portal messages.

AccurKardia's AccurECG wins "Best New Technology Solution for ECG," revolutionizing cardiac diagnostics with AI-driven, real-time ECG analysis for better patient outcomes.

Osteoboost introduces a groundbreaking FDA-cleared device for osteoporosis, offering innovative, non-invasive therapy to enhance bone health and prevent fractures.

A new whitepaper by LeagueMed’s founders offers a practical roadmap for turning early-stage MedTech innovations into successful businesses.

Imperative Care enhances stroke treatment with Zoom DuoPort, enabling efficient dual aspiration for faster, more effective thrombectomy procedures.

BrightHeart's FDA-cleared AI platform enhances fetal heart screenings, improving detection of congenital heart defects during ultrasounds with real-time analysis.

HeartBeam's innovative 3D ECG technology revolutionizes cardiac monitoring, enhancing remote patient care and enabling timely interventions for heart conditions.

The Jewel Patch-WCD offers a discreet solution for patients at risk of cardiac arrest, enhancing safety and daily life integration.

Myomo's MyoPro 2x revolutionizes upper-limb paralysis treatment, enhancing independence with advanced myoelectric orthoses for improved user experience and clinical outcomes.

GE HealthCare showcases strong Q1 earnings with revenue growth, strategic acquisitions, and new product launches, despite adjusting full-year guidance due to tariffs.